ReP USP - Resultado da busca

Artigo de periodico
L-Asparaginase as the gold standard in the treatment of acute lymphoblastic leukemia: a comprehensive review (2023)
Pérez, Maria Tosta; Belén, Lisandra Herrera ; Letelier, Pablo ; Calle, Yolanda; Pessoa Junior, Adalberto ; Farías, Jorge G
Source: Medical Oncology. Unidade: FCF
Subjects: LEUCEMIA, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PÉREZ, Maria Tosta et al. L-Asparaginase as the gold standard in the treatment of acute lymphoblastic leukemia: a comprehensive review. Medical Oncology, v. 40, n. 5, p. 1-15, 2023Tradução . . Disponível em: https://doi.org/10.1007/s12032-023-02014-9. Acesso em: 03 jun. 2024.
APA
Pérez, M. T., Belén, L. H., Letelier, P., Calle, Y., Pessoa Junior, A., & Farías, J. G. (2023). L-Asparaginase as the gold standard in the treatment of acute lymphoblastic leukemia: a comprehensive review. Medical Oncology, 40( 5), 1-15. doi:10.1007/s12032-023-02014-9
NLM
Pérez MT, Belén LH, Letelier P, Calle Y, Pessoa Junior A, Farías JG. L-Asparaginase as the gold standard in the treatment of acute lymphoblastic leukemia: a comprehensive review [Internet]. Medical Oncology. 2023 ; 40( 5): 1-15.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-023-02014-9
Vancouver
Pérez MT, Belén LH, Letelier P, Calle Y, Pessoa Junior A, Farías JG. L-Asparaginase as the gold standard in the treatment of acute lymphoblastic leukemia: a comprehensive review [Internet]. Medical Oncology. 2023 ; 40( 5): 1-15.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-023-02014-9
Artigo de periodico
Genetic polymorphism of calcium-sensing receptor in women with breast cancer (2018)
Campos-Verdes, Larysse Maira ; da Silva-Sampaio, João Paulo ; Costa-Silva, Danylo Rafhael ; de Oliveira, Victor Alves; Junior, Airton Mendes Conde ; Silva, Vladimir Costa ; Alencar, Airlane Pereira ; Campelo, Viriato ; Lopes-costa, Pedro vitor; Gebrim, Luiz Henrique ; da Silva, Benedito Borges
Source: Medical Oncology. Unidade: IME
Subjects: CÁLCIO, POLIMORFISMO, MENOPAUSA, CARCINOMA, ESTATÍSTICA APLICADA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS-VERDES, Larysse Maira et al. Genetic polymorphism of calcium-sensing receptor in women with breast cancer. Medical Oncology, v. 35, n. 3, p. 1-4, 2018Tradução . . Disponível em: https://doi.org/10.1007/s12032-018-1089-4. Acesso em: 03 jun. 2024.
APA
Campos-Verdes, L. M., da Silva-Sampaio, J. P., Costa-Silva, D. R., de Oliveira, V. A., Junior, A. M. C., Silva, V. C., et al. (2018). Genetic polymorphism of calcium-sensing receptor in women with breast cancer. Medical Oncology, 35( 3), 1-4. doi:10.1007/s12032-018-1089-4
NLM
Campos-Verdes LM, da Silva-Sampaio JP, Costa-Silva DR, de Oliveira VA, Junior AMC, Silva VC, Alencar AP, Campelo V, Lopes-costa P vitor, Gebrim LH, da Silva BB. Genetic polymorphism of calcium-sensing receptor in women with breast cancer [Internet]. Medical Oncology. 2018 ; 35( 3): 1-4.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-018-1089-4
Vancouver
Campos-Verdes LM, da Silva-Sampaio JP, Costa-Silva DR, de Oliveira VA, Junior AMC, Silva VC, Alencar AP, Campelo V, Lopes-costa P vitor, Gebrim LH, da Silva BB. Genetic polymorphism of calcium-sensing receptor in women with breast cancer [Internet]. Medical Oncology. 2018 ; 35( 3): 1-4.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-018-1089-4
Artigo de periodico
Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma (2017)
Graziani, Silvia Regina; Vital, Carolina Graziani; Morikawa, Aleksandra Tiemi; Eyll, Brigitte M. Van; Fernandes Júnior, Hézio Jadir; Kalil Filho, Roberto; Maranhão, Raul Cavalcante
Source: Medical Oncology. Unidades: FM, FCF
Subjects: NANOPARTÍCULAS, CARCINOMA, OVÁRIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GRAZIANI, Silvia Regina et al. Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma. Medical Oncology, v. 34, p. 1-7 art. 151, 2017Tradução . . Disponível em: https://doi.org/10.1007/s12032-017-1009-z. Acesso em: 03 jun. 2024.
APA
Graziani, S. R., Vital, C. G., Morikawa, A. T., Eyll, B. M. V., Fernandes Júnior, H. J., Kalil Filho, R., & Maranhão, R. C. (2017). Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma. Medical Oncology, 34, 1-7 art. 151. doi:10.1007/s12032-017-1009-z
NLM
Graziani SR, Vital CG, Morikawa AT, Eyll BMV, Fernandes Júnior HJ, Kalil Filho R, Maranhão RC. Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma [Internet]. Medical Oncology. 2017 ; 34 1-7 art. 151.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-017-1009-z
Vancouver
Graziani SR, Vital CG, Morikawa AT, Eyll BMV, Fernandes Júnior HJ, Kalil Filho R, Maranhão RC. Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma [Internet]. Medical Oncology. 2017 ; 34 1-7 art. 151.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-017-1009-z
Artigo de periodico
Insulin-like growth factor 1 gene polymorphism in women with breast cancer (2017)
Costa-Silva, Danylo Rafhael; Barros-Oliveira, Maria da Conceicão; Borges, Rafael Soares; Campos-Verdes, Larysse Maira; Silva-Sampaio, João Paulo da; Escorcio-Dourado, Carla Solange; Martins, Luana Mota; Alencar, Airlane Pereira ; Baracat, Edmund Chada; Silva, Vladimir Costa; Silva, Benedito Borges da
Source: Medical Oncology. Unidades: IME, FM
Subjects: NEOPLASIAS MAMÁRIAS, POLIMORFISMO, REAÇÃO EM CADEIA POR POLIMERASE, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA-SILVA, Danylo Rafhael et al. Insulin-like growth factor 1 gene polymorphism in women with breast cancer. Medical Oncology, v. 34, p. 5 , 2017Tradução . . Disponível em: https://doi.org/10.1007/s12032-017-0915-4. Acesso em: 03 jun. 2024.
APA
Costa-Silva, D. R., Barros-Oliveira, M. da C., Borges, R. S., Campos-Verdes, L. M., Silva-Sampaio, J. P. da, Escorcio-Dourado, C. S., et al. (2017). Insulin-like growth factor 1 gene polymorphism in women with breast cancer. Medical Oncology, 34, 5 . doi:10.1007/s12032-017-0915-4
NLM
Costa-Silva DR, Barros-Oliveira M da C, Borges RS, Campos-Verdes LM, Silva-Sampaio JP da, Escorcio-Dourado CS, Martins LM, Alencar AP, Baracat EC, Silva VC, Silva BB da. Insulin-like growth factor 1 gene polymorphism in women with breast cancer [Internet]. Medical Oncology. 2017 ; 34 5 .[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-017-0915-4
Vancouver
Costa-Silva DR, Barros-Oliveira M da C, Borges RS, Campos-Verdes LM, Silva-Sampaio JP da, Escorcio-Dourado CS, Martins LM, Alencar AP, Baracat EC, Silva VC, Silva BB da. Insulin-like growth factor 1 gene polymorphism in women with breast cancer [Internet]. Medical Oncology. 2017 ; 34 5 .[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-017-0915-4
Artigo de periodico
Effect of the association of 1-methyl-DL-tryptophan with paclitaxel on the expression of indoleamine 2,3-dioxygenase in cultured cancer cells from patients with breast cancer (2015)
Salvadori, Maria Letícia Baptista; Bianchi, Pedro Kastein Faria da Cunha; Gebrim, Luiz Henrique; Silva, Renata Santos; Kfoury Junior, José Roberto
Source: Medical Oncology. Unidade: FMVZ
Subjects: CITOMETRIA DE FLUXO, FARMACOCINÉTICA, NEOPLASIAS MAMÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALVADORI, Maria Letícia Baptista et al. Effect of the association of 1-methyl-DL-tryptophan with paclitaxel on the expression of indoleamine 2,3-dioxygenase in cultured cancer cells from patients with breast cancer. Medical Oncology, v. 32, n. 11, 2015Tradução . . Disponível em: https://doi.org/10.1007/s12032-015-0694-8. Acesso em: 03 jun. 2024.
APA
Salvadori, M. L. B., Bianchi, P. K. F. da C., Gebrim, L. H., Silva, R. S., & Kfoury Junior, J. R. (2015). Effect of the association of 1-methyl-DL-tryptophan with paclitaxel on the expression of indoleamine 2,3-dioxygenase in cultured cancer cells from patients with breast cancer. Medical Oncology, 32( 11). doi:10.1007/s12032-015-0694-8
NLM
Salvadori MLB, Bianchi PKF da C, Gebrim LH, Silva RS, Kfoury Junior JR. Effect of the association of 1-methyl-DL-tryptophan with paclitaxel on the expression of indoleamine 2,3-dioxygenase in cultured cancer cells from patients with breast cancer [Internet]. Medical Oncology. 2015 ; 32( 11):[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-015-0694-8
Vancouver
Salvadori MLB, Bianchi PKF da C, Gebrim LH, Silva RS, Kfoury Junior JR. Effect of the association of 1-methyl-DL-tryptophan with paclitaxel on the expression of indoleamine 2,3-dioxygenase in cultured cancer cells from patients with breast cancer [Internet]. Medical Oncology. 2015 ; 32( 11):[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-015-0694-8
Artigo de periodico
Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia (2014)
Lima, Luciene Terezinha de; Vivona, Douglas; Bueno, Carolina Tosin; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Luchessi, André Ducati; Castro, Fabíola Attié de; Chauffaille, Maria de Lourdes L. F; Zanichelli, Maria Aparecida; Chiattone, Carlos Sérgio; Hungria, Vania Tietsche de Moraes; Guerra-Shinohara, Elvira Maria
Source: Medical Oncology. Unidades: FCF, FCFRP
Subjects: LEUCEMIA MIELOIDE, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Luciene Terezinha de et al. Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia. Medical Oncology, v. 31, p. 1-11, 2014Tradução . . Disponível em: https://doi.org/10.1007/s12032-014-0851-5. Acesso em: 03 jun. 2024.
APA
Lima, L. T. de, Vivona, D., Bueno, C. T., Hirata, R. D. C., Hirata, M. H., Luchessi, A. D., et al. (2014). Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia. Medical Oncology, 31, 1-11. doi:10.1007/s12032-014-0851-5
NLM
Lima LT de, Vivona D, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Castro FA de, Chauffaille M de LLF, Zanichelli MA, Chiattone CS, Hungria VT de M, Guerra-Shinohara EM. Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia [Internet]. Medical Oncology. 2014 ; 31 1-11.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-014-0851-5
Vancouver
Lima LT de, Vivona D, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Castro FA de, Chauffaille M de LLF, Zanichelli MA, Chiattone CS, Hungria VT de M, Guerra-Shinohara EM. Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia [Internet]. Medical Oncology. 2014 ; 31 1-11.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-014-0851-5
Artigo de periodico
Mantle cell lymphoma harboring Burkitt’s-like translocations presents differential expression of aurora kinase genes compared with others 8q abnormalities (2014)
Oliveira, Fábio Morato de; Rodrigues-Alves, Ana Paula Nunes; Lucena-Araújo, Antônio Roberto; Silva, Ferdinando de Paula; Silva, Fernanda Borges da; Falcao, Roberto Passetto
Source: Medical Oncology. Unidade: FMRP
Subjects: LINFOMA (GENÉTICA;METABOLISMO), MAPEAMENTO CROMOSSÔMICO, CROMOSSOMOS HUMANOS, PROTEÍNAS PROTO-ONCOGÊNICAS, REAÇÃO EM CADEIA POR POLIMERASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Fábio Morato de et al. Mantle cell lymphoma harboring Burkitt’s-like translocations presents differential expression of aurora kinase genes compared with others 8q abnormalities. Medical Oncology, v. 31, n. 5, 2014Tradução . . Disponível em: https://doi.org/10.1007/s12032-014-0931-6. Acesso em: 03 jun. 2024.
APA
Oliveira, F. M. de, Rodrigues-Alves, A. P. N., Lucena-Araújo, A. R., Silva, F. de P., Silva, F. B. da, & Falcao, R. P. (2014). Mantle cell lymphoma harboring Burkitt’s-like translocations presents differential expression of aurora kinase genes compared with others 8q abnormalities. Medical Oncology, 31( 5). doi:10.1007/s12032-014-0931-6
NLM
Oliveira FM de, Rodrigues-Alves APN, Lucena-Araújo AR, Silva F de P, Silva FB da, Falcao RP. Mantle cell lymphoma harboring Burkitt’s-like translocations presents differential expression of aurora kinase genes compared with others 8q abnormalities [Internet]. Medical Oncology. 2014 ; 31( 5):[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-014-0931-6
Vancouver
Oliveira FM de, Rodrigues-Alves APN, Lucena-Araújo AR, Silva F de P, Silva FB da, Falcao RP. Mantle cell lymphoma harboring Burkitt’s-like translocations presents differential expression of aurora kinase genes compared with others 8q abnormalities [Internet]. Medical Oncology. 2014 ; 31( 5):[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-014-0931-6
Artigo de periodico
Pre-treatment neutrophil-to-lymphocyte ratio affects survival in patients with advanced hepatocellular carcinoma treated with sorafenib (2014)
Fonseca, Leonardo Gomes da; Barroso-Sousa, Romulado; Bento, Afonso da Silva Alves; Blanco, Bruna Paccola; Valente, Gabriel Luis; Pfiffer, Tulio Eduardo Flesch; Hoff, Paulo Marcelo; Sabbaga, Jorge
Source: Medical Oncology. Unidade: FM
Subjects: NEOPLASIAS HEPÁTICAS (TERAPIA), TAXA DE SOBREVIVÊNCIA, PROGNÓSTICO, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FONSECA, Leonardo Gomes da et al. Pre-treatment neutrophil-to-lymphocyte ratio affects survival in patients with advanced hepatocellular carcinoma treated with sorafenib. Medical Oncology, v. 31, p. 1-6, 2014Tradução . . Disponível em: https://doi.org/10.1007/s12032-014-0264-5. Acesso em: 03 jun. 2024.
APA
Fonseca, L. G. da, Barroso-Sousa, R., Bento, A. da S. A., Blanco, B. P., Valente, G. L., Pfiffer, T. E. F., et al. (2014). Pre-treatment neutrophil-to-lymphocyte ratio affects survival in patients with advanced hepatocellular carcinoma treated with sorafenib. Medical Oncology, 31, 1-6. doi:10.1007/s12032-014-0264-5
NLM
Fonseca LG da, Barroso-Sousa R, Bento A da SA, Blanco BP, Valente GL, Pfiffer TEF, Hoff PM, Sabbaga J. Pre-treatment neutrophil-to-lymphocyte ratio affects survival in patients with advanced hepatocellular carcinoma treated with sorafenib [Internet]. Medical Oncology. 2014 ; 31 1-6.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-014-0264-5
Vancouver
Fonseca LG da, Barroso-Sousa R, Bento A da SA, Blanco BP, Valente GL, Pfiffer TEF, Hoff PM, Sabbaga J. Pre-treatment neutrophil-to-lymphocyte ratio affects survival in patients with advanced hepatocellular carcinoma treated with sorafenib [Internet]. Medical Oncology. 2014 ; 31 1-6.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-014-0264-5
Artigo de periodico
FISH analysis for TET2 deletion in a cohort of 362 Brazilian myeloid malignancies: correlation with karyotype abnormalities (2013)
Oliveira, Fábio Morato de; Miguel, Carlos Eduardo; Araújo, Antonio Roberto Lucena; Lima, Ana Silvia Gouvêa de; Falcao, Roberto Passetto; Rego, Eduardo Magalhaes
Source: Medical Oncology. Unidade: FMRP
Subjects: IDOSOS, LEUCEMIA MIELOIDE AGUDA, PROTEÍNAS PROTO-ONCOGÊNICAS, HIBRIDIZAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Fábio Morato de et al. FISH analysis for TET2 deletion in a cohort of 362 Brazilian myeloid malignancies: correlation with karyotype abnormalities. Medical Oncology, v. 30, n. 1, 2013Tradução . . Disponível em: https://doi.org/10.1007/s12032-013-0483-1. Acesso em: 03 jun. 2024.
APA
Oliveira, F. M. de, Miguel, C. E., Araújo, A. R. L., Lima, A. S. G. de, Falcao, R. P., & Rego, E. M. (2013). FISH analysis for TET2 deletion in a cohort of 362 Brazilian myeloid malignancies: correlation with karyotype abnormalities. Medical Oncology, 30( 1). doi:10.1007/s12032-013-0483-1
NLM
Oliveira FM de, Miguel CE, Araújo ARL, Lima ASG de, Falcao RP, Rego EM. FISH analysis for TET2 deletion in a cohort of 362 Brazilian myeloid malignancies: correlation with karyotype abnormalities [Internet]. Medical Oncology. 2013 ; 30( 1):[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-013-0483-1
Vancouver
Oliveira FM de, Miguel CE, Araújo ARL, Lima ASG de, Falcao RP, Rego EM. FISH analysis for TET2 deletion in a cohort of 362 Brazilian myeloid malignancies: correlation with karyotype abnormalities [Internet]. Medical Oncology. 2013 ; 30( 1):[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-013-0483-1
Artigo de periodico
Application of five prognostic survival scores to primary myelofibrosis in 62 Brazilian patients (2013)
Souza, M. C; Rodrigues, C. A; Silva, M. R. R; Ribeiro, J.; Tognon, R.; Castro, Fabíola Attié de; Simoes, Belinda Pinto; Souto, E. X; Chauffaille, M. L
Source: Medical Oncology. Unidades: FCFRP, FMRP
Subjects: IDOSOS, DOENÇAS HEMATOLÓGICAS, PROTEÍNAS QUINASES, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, M. C et al. Application of five prognostic survival scores to primary myelofibrosis in 62 Brazilian patients. Medical Oncology, v. 30, n. 2, 2013Tradução . . Disponível em: https://doi.org/10.1007/s12032-013-0555-2. Acesso em: 03 jun. 2024.
APA
Souza, M. C., Rodrigues, C. A., Silva, M. R. R., Ribeiro, J., Tognon, R., Castro, F. A. de, et al. (2013). Application of five prognostic survival scores to primary myelofibrosis in 62 Brazilian patients. Medical Oncology, 30( 2). doi:10.1007/s12032-013-0555-2
NLM
Souza MC, Rodrigues CA, Silva MRR, Ribeiro J, Tognon R, Castro FA de, Simoes BP, Souto EX, Chauffaille ML. Application of five prognostic survival scores to primary myelofibrosis in 62 Brazilian patients [Internet]. Medical Oncology. 2013 ; 30( 2):[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-013-0555-2
Vancouver
Souza MC, Rodrigues CA, Silva MRR, Ribeiro J, Tognon R, Castro FA de, Simoes BP, Souto EX, Chauffaille ML. Application of five prognostic survival scores to primary myelofibrosis in 62 Brazilian patients [Internet]. Medical Oncology. 2013 ; 30( 2):[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-013-0555-2
Artigo de periodico
CD44+/CD24- cells and lymph node metastasis in stage I and II invasive ductal carcinoma of the breast (2012)
Tiezzi, Daniel Guimarães; Valejo, Fernando Antonio Mourão; Marana, Heitor Ricardo Cosiski; Carrara, Helio Humberto Angotti; Benevides, Luciana; Antonio, Heriton Marcelo Ribeiro; Sicchieri, Renata Danielle; Milanezi, Cristiane Maria; Silva, João Santana da; Andrade, Jurandyr Moreira de
Source: Medical Oncology. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS, METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TIEZZI, Daniel Guimarães et al. CD44+/CD24- cells and lymph node metastasis in stage I and II invasive ductal carcinoma of the breast. Medical Oncology, v. 29, n. 3, p. 1479-1485, 2012Tradução . . Disponível em: https://doi.org/10.1007/s12032-011-0014-x. Acesso em: 03 jun. 2024.
APA
Tiezzi, D. G., Valejo, F. A. M., Marana, H. R. C., Carrara, H. H. A., Benevides, L., Antonio, H. M. R., et al. (2012). CD44+/CD24- cells and lymph node metastasis in stage I and II invasive ductal carcinoma of the breast. Medical Oncology, 29( 3), 1479-1485. doi:10.1007/s12032-011-0014-x
NLM
Tiezzi DG, Valejo FAM, Marana HRC, Carrara HHA, Benevides L, Antonio HMR, Sicchieri RD, Milanezi CM, Silva JS da, Andrade JM de. CD44+/CD24- cells and lymph node metastasis in stage I and II invasive ductal carcinoma of the breast [Internet]. Medical Oncology. 2012 ; 29( 3): 1479-1485.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-011-0014-x
Vancouver
Tiezzi DG, Valejo FAM, Marana HRC, Carrara HHA, Benevides L, Antonio HMR, Sicchieri RD, Milanezi CM, Silva JS da, Andrade JM de. CD44+/CD24- cells and lymph node metastasis in stage I and II invasive ductal carcinoma of the breast [Internet]. Medical Oncology. 2012 ; 29( 3): 1479-1485.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-011-0014-x
Artigo de periodico
Safety and efficacy of gemcitabine plus cisplatin combination in pretreated metastatic breast cancer patients (2012)
Brito, Luiz Gustavo Oliveira; Andrade, Jurandyr Moreira de; Lins-Almeida, Thiago; Zola, Fábio Eduardo; Pinheiro, Mariana Novaes; Marana, Heitor Ricardo Cosiski; Tiezzi, Daniel Guimarães; Peria, Fernanda Maris
Source: Medical Oncology. Unidade: FMRP
Subjects: ESTUDOS RETROSPECTIVOS, NEOPLASIAS MAMÁRIAS, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRITO, Luiz Gustavo Oliveira et al. Safety and efficacy of gemcitabine plus cisplatin combination in pretreated metastatic breast cancer patients. Medical Oncology, v. 29, n. 1, p. 33-38, 2012Tradução . . Disponível em: https://doi.org/10.1007/s12032-010-9793-8. Acesso em: 03 jun. 2024.
APA
Brito, L. G. O., Andrade, J. M. de, Lins-Almeida, T., Zola, F. E., Pinheiro, M. N., Marana, H. R. C., et al. (2012). Safety and efficacy of gemcitabine plus cisplatin combination in pretreated metastatic breast cancer patients. Medical Oncology, 29( 1), 33-38. doi:10.1007/s12032-010-9793-8
NLM
Brito LGO, Andrade JM de, Lins-Almeida T, Zola FE, Pinheiro MN, Marana HRC, Tiezzi DG, Peria FM. Safety and efficacy of gemcitabine plus cisplatin combination in pretreated metastatic breast cancer patients [Internet]. Medical Oncology. 2012 ; 29( 1): 33-38.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-010-9793-8
Vancouver
Brito LGO, Andrade JM de, Lins-Almeida T, Zola FE, Pinheiro MN, Marana HRC, Tiezzi DG, Peria FM. Safety and efficacy of gemcitabine plus cisplatin combination in pretreated metastatic breast cancer patients [Internet]. Medical Oncology. 2012 ; 29( 1): 33-38.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-010-9793-8
Artigo de periodico
Acute promyelocytic leukemia associated with the PLZF-RARA fusion gene: two additional cases with clinical and laboratorial peculiar presentations (2012)
Rohr, Sandra S.; Pelloso, Luís Arthur Flores; Borgo, Aline; De Nadai, Livia Chiosini; Yamamoto, Mihoko; Rego, Eduardo Magalhaes; Chauffaile, Maria de Lourdes L. F.
Source: Medical Oncology. Unidade: FMRP
Subjects: LEUCEMIA MIELOIDE AGUDA, CITOGENÉTICA, ESTUDO DE CASO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROHR, Sandra S. et al. Acute promyelocytic leukemia associated with the PLZF-RARA fusion gene: two additional cases with clinical and laboratorial peculiar presentations. Medical Oncology, v. 29, n. 4, p. 2345-2347, 2012Tradução . . Disponível em: https://doi.org/10.1007/s12032-011-0147-y. Acesso em: 03 jun. 2024.
APA
Rohr, S. S., Pelloso, L. A. F., Borgo, A., De Nadai, L. C., Yamamoto, M., Rego, E. M., & Chauffaile, M. de L. L. F. (2012). Acute promyelocytic leukemia associated with the PLZF-RARA fusion gene: two additional cases with clinical and laboratorial peculiar presentations. Medical Oncology, 29( 4), 2345-2347. doi:10.1007/s12032-011-0147-y
NLM
Rohr SS, Pelloso LAF, Borgo A, De Nadai LC, Yamamoto M, Rego EM, Chauffaile M de LLF. Acute promyelocytic leukemia associated with the PLZF-RARA fusion gene: two additional cases with clinical and laboratorial peculiar presentations [Internet]. Medical Oncology. 2012 ; 29( 4): 2345-2347.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-011-0147-y
Vancouver
Rohr SS, Pelloso LAF, Borgo A, De Nadai LC, Yamamoto M, Rego EM, Chauffaile M de LLF. Acute promyelocytic leukemia associated with the PLZF-RARA fusion gene: two additional cases with clinical and laboratorial peculiar presentations [Internet]. Medical Oncology. 2012 ; 29( 4): 2345-2347.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-011-0147-y
Artigo de periodico
A new dic(7;12)(p12.21;p12.2) and i(12)(q10) during the lymphoid blast crisis of patient with Ph+ chronic myeloid leukemia (2012)
Oliveira, Fábio Morato de; Palma, Leonardo de Carvalho; Falcao, Roberto Passetto; Simoes, Belinda Pinto
Source: Medical Oncology. Unidade: FMRP
Subjects: LEUCEMIA MIELOIDE AGUDA, CITOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Fábio Morato de et al. A new dic(7;12)(p12.21;p12.2) and i(12)(q10) during the lymphoid blast crisis of patient with Ph+ chronic myeloid leukemia. Medical Oncology, v. 29, n. 4, p. 2332-2336, 2012Tradução . . Disponível em: https://doi.org/10.1007/s12032-011-0142-3. Acesso em: 03 jun. 2024.
APA
Oliveira, F. M. de, Palma, L. de C., Falcao, R. P., & Simoes, B. P. (2012). A new dic(7;12)(p12.21;p12.2) and i(12)(q10) during the lymphoid blast crisis of patient with Ph+ chronic myeloid leukemia. Medical Oncology, 29( 4), 2332-2336. doi:10.1007/s12032-011-0142-3
NLM
Oliveira FM de, Palma L de C, Falcao RP, Simoes BP. A new dic(7;12)(p12.21;p12.2) and i(12)(q10) during the lymphoid blast crisis of patient with Ph+ chronic myeloid leukemia [Internet]. Medical Oncology. 2012 ; 29( 4): 2332-2336.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-011-0142-3
Vancouver
Oliveira FM de, Palma L de C, Falcao RP, Simoes BP. A new dic(7;12)(p12.21;p12.2) and i(12)(q10) during the lymphoid blast crisis of patient with Ph+ chronic myeloid leukemia [Internet]. Medical Oncology. 2012 ; 29( 4): 2332-2336.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-011-0142-3
Artigo de periodico
Identification of a new translocation that disrupts the RUNX1 gene in a patient with de novo acute myeloid leukemia (2012)
Lucena-Araujo, Antonio Roberto; Figueiredo-Pontes, Lorena Lobo; Oliveira, Fábio Morato de; Chauffaille, Maria de Lourdes; Falcao, Roberto Passetto; Rego, Eduardo Magalhaes
Source: Medical Oncology. Unidade: FMRP
Subjects: LEUCEMIA MIELOIDE AGUDA, CITOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUCENA-ARAUJO, Antonio Roberto et al. Identification of a new translocation that disrupts the RUNX1 gene in a patient with de novo acute myeloid leukemia. Medical Oncology, v. 29, n. 2, p. 1114-1118, 2012Tradução . . Disponível em: https://doi.org/10.1007/s12032-011-9890-3. Acesso em: 03 jun. 2024.
APA
Lucena-Araujo, A. R., Figueiredo-Pontes, L. L., Oliveira, F. M. de, Chauffaille, M. de L., Falcao, R. P., & Rego, E. M. (2012). Identification of a new translocation that disrupts the RUNX1 gene in a patient with de novo acute myeloid leukemia. Medical Oncology, 29( 2), 1114-1118. doi:10.1007/s12032-011-9890-3
NLM
Lucena-Araujo AR, Figueiredo-Pontes LL, Oliveira FM de, Chauffaille M de L, Falcao RP, Rego EM. Identification of a new translocation that disrupts the RUNX1 gene in a patient with de novo acute myeloid leukemia [Internet]. Medical Oncology. 2012 ; 29( 2): 1114-1118.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-011-9890-3
Vancouver
Lucena-Araujo AR, Figueiredo-Pontes LL, Oliveira FM de, Chauffaille M de L, Falcao RP, Rego EM. Identification of a new translocation that disrupts the RUNX1 gene in a patient with de novo acute myeloid leukemia [Internet]. Medical Oncology. 2012 ; 29( 2): 1114-1118.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-011-9890-3
Artigo de periodico
Monoclonal B-cell lymphocytosis (MBL), CD4+/CD8weak T-cell large granular lymphocytic leukemia (T-LGL leukemia) and monoclonal gammopathy of unknown significance (MGUS): molecular and flow cytometry characterization of three concomitant hematological disorders (2012)
Matos, Daniel Mazza; Oliveira, Ana Cesarino Vitoriano de; Tomé, Maria de Nazaré Amaral; Scrideli, Carlos Alberto
Source: Medical Oncology. Unidade: FMRP
Subjects: LEUCEMIA, CITOMETRIA DE FLUXO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATOS, Daniel Mazza et al. Monoclonal B-cell lymphocytosis (MBL), CD4+/CD8weak T-cell large granular lymphocytic leukemia (T-LGL leukemia) and monoclonal gammopathy of unknown significance (MGUS): molecular and flow cytometry characterization of three concomitant hematological disorders. Medical Oncology, v. 29, n. 5, p. 3557-3560, 2012Tradução . . Disponível em: https://doi.org/10.1007/s12032-012-0271-3. Acesso em: 03 jun. 2024.
APA
Matos, D. M., Oliveira, A. C. V. de, Tomé, M. de N. A., & Scrideli, C. A. (2012). Monoclonal B-cell lymphocytosis (MBL), CD4+/CD8weak T-cell large granular lymphocytic leukemia (T-LGL leukemia) and monoclonal gammopathy of unknown significance (MGUS): molecular and flow cytometry characterization of three concomitant hematological disorders. Medical Oncology, 29( 5), 3557-3560. doi:10.1007/s12032-012-0271-3
NLM
Matos DM, Oliveira ACV de, Tomé M de NA, Scrideli CA. Monoclonal B-cell lymphocytosis (MBL), CD4+/CD8weak T-cell large granular lymphocytic leukemia (T-LGL leukemia) and monoclonal gammopathy of unknown significance (MGUS): molecular and flow cytometry characterization of three concomitant hematological disorders [Internet]. Medical Oncology. 2012 ; 29( 5): 3557-3560.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-012-0271-3
Vancouver
Matos DM, Oliveira ACV de, Tomé M de NA, Scrideli CA. Monoclonal B-cell lymphocytosis (MBL), CD4+/CD8weak T-cell large granular lymphocytic leukemia (T-LGL leukemia) and monoclonal gammopathy of unknown significance (MGUS): molecular and flow cytometry characterization of three concomitant hematological disorders [Internet]. Medical Oncology. 2012 ; 29( 5): 3557-3560.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-012-0271-3
Artigo de periodico
Co-existence of t(6;13)(p21;q14.1) and trisomy 12 in chronic lymphocytic leukemia (2012)
Oliveira, Fábio Morato de; Pontes, Lorena Lobo de Figueiredo; Bassi, Sarah Cristina; Dalmazzo, Leandro Felipe Figueiredo; Falcao, Roberto Passetto
Source: Medical Oncology. Unidade: FMRP
Subjects: LEUCEMIA, CITOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Fábio Morato de et al. Co-existence of t(6;13)(p21;q14.1) and trisomy 12 in chronic lymphocytic leukemia. Medical Oncology, v. 29, n. 2, p. 1227-1230, 2012Tradução . . Disponível em: https://doi.org/10.1007/s12032-011-9957-1. Acesso em: 03 jun. 2024.
APA
Oliveira, F. M. de, Pontes, L. L. de F., Bassi, S. C., Dalmazzo, L. F. F., & Falcao, R. P. (2012). Co-existence of t(6;13)(p21;q14.1) and trisomy 12 in chronic lymphocytic leukemia. Medical Oncology, 29( 2), 1227-1230. doi:10.1007/s12032-011-9957-1
NLM
Oliveira FM de, Pontes LL de F, Bassi SC, Dalmazzo LFF, Falcao RP. Co-existence of t(6;13)(p21;q14.1) and trisomy 12 in chronic lymphocytic leukemia [Internet]. Medical Oncology. 2012 ; 29( 2): 1227-1230.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-011-9957-1
Vancouver
Oliveira FM de, Pontes LL de F, Bassi SC, Dalmazzo LFF, Falcao RP. Co-existence of t(6;13)(p21;q14.1) and trisomy 12 in chronic lymphocytic leukemia [Internet]. Medical Oncology. 2012 ; 29( 2): 1227-1230.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-011-9957-1
Artigo de periodico
Taxane-based chemotherapy enhances response to neoadjuvant treatment for stage II and III breast cancer (2011)
Andrade, J. M.; Carrara, Helio Humberto Angotti; Pimentel, Flanklin Fernandes; Marana, Heitor Ricardo Cosiski; Macchetti, Alexandre Henrique; Mouro, Larissa R.; Zola, Fábio Eduardo; Tiezzi, Daniel Guimarães
Source: Medical Oncology. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS (CIRURGIA;CONSERVAÇÃO), QUIMIOTERAPIA ADJUVANTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, J. M. et al. Taxane-based chemotherapy enhances response to neoadjuvant treatment for stage II and III breast cancer. Medical Oncology, v. 28, p. s65-s69, 2011Tradução . . Disponível em: https://doi.org/10.1007/s12032-010-9711-0. Acesso em: 03 jun. 2024.
APA
Andrade, J. M., Carrara, H. H. A., Pimentel, F. F., Marana, H. R. C., Macchetti, A. H., Mouro, L. R., et al. (2011). Taxane-based chemotherapy enhances response to neoadjuvant treatment for stage II and III breast cancer. Medical Oncology, 28, s65-s69. doi:10.1007/s12032-010-9711-0
NLM
Andrade JM, Carrara HHA, Pimentel FF, Marana HRC, Macchetti AH, Mouro LR, Zola FE, Tiezzi DG. Taxane-based chemotherapy enhances response to neoadjuvant treatment for stage II and III breast cancer [Internet]. Medical Oncology. 2011 ; 28 s65-s69.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-010-9711-0
Vancouver
Andrade JM, Carrara HHA, Pimentel FF, Marana HRC, Macchetti AH, Mouro LR, Zola FE, Tiezzi DG. Taxane-based chemotherapy enhances response to neoadjuvant treatment for stage II and III breast cancer [Internet]. Medical Oncology. 2011 ; 28 s65-s69.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-010-9711-0
Artigo de periodico
A 23-year-old woman with 11q-chronic lymphocytic leukemia (2011)
Miguel, Carlos Eduardo; Oliveira, Fábio Morato de; Leite-Cueva, Sabrina Dias; Rego, Eduardo Magalhaes; Falcao, Roberto Passetto
Source: Medical Oncology. Unidade: FMRP
Subjects: TRANSPLANTE DE MEDULA ÓSSEA, LEUCEMIA (GENÉTICA;FISIOPATOLOGIA), CROMOSSOMOS HUMANOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIGUEL, Carlos Eduardo et al. A 23-year-old woman with 11q-chronic lymphocytic leukemia. Medical Oncology, v. 28, n. 4, p. 1534-1536, 2011Tradução . . Disponível em: https://doi.org/10.1007/s12032-010-9545-9. Acesso em: 03 jun. 2024.
APA
Miguel, C. E., Oliveira, F. M. de, Leite-Cueva, S. D., Rego, E. M., & Falcao, R. P. (2011). A 23-year-old woman with 11q-chronic lymphocytic leukemia. Medical Oncology, 28( 4), 1534-1536. doi:10.1007/s12032-010-9545-9
NLM
Miguel CE, Oliveira FM de, Leite-Cueva SD, Rego EM, Falcao RP. A 23-year-old woman with 11q-chronic lymphocytic leukemia [Internet]. Medical Oncology. 2011 ; 28( 4): 1534-1536.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-010-9545-9
Vancouver
Miguel CE, Oliveira FM de, Leite-Cueva SD, Rego EM, Falcao RP. A 23-year-old woman with 11q-chronic lymphocytic leukemia [Internet]. Medical Oncology. 2011 ; 28( 4): 1534-1536.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-010-9545-9
Artigo de periodico
Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil (2010)
Oliveira, Luciana Correa Oliveira de; Romano, Lucas Gabriel M.; Prado Júnior, Benedito de Pina Almeida; Covas, Dimas Tadeu; Rego, Eduardo Magalhaes; Santis, Gil Cunha de
Source: Medical Oncology. Unidade: FMRP
Subjects: LEUCEMIA, LEUCÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Luciana Correa Oliveira de et al. Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil. Medical Oncology, v. 27, n. 4, p. 1254-1259, 2010Tradução . . Disponível em: https://doi.org/10.1007/s12032-009-9367-9. Acesso em: 03 jun. 2024.
APA
Oliveira, L. C. O. de, Romano, L. G. M., Prado Júnior, B. de P. A., Covas, D. T., Rego, E. M., & Santis, G. C. de. (2010). Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil. Medical Oncology, 27( 4), 1254-1259. doi:10.1007/s12032-009-9367-9
NLM
Oliveira LCO de, Romano LGM, Prado Júnior B de PA, Covas DT, Rego EM, Santis GC de. Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil [Internet]. Medical Oncology. 2010 ; 27( 4): 1254-1259.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-009-9367-9
Vancouver
Oliveira LCO de, Romano LGM, Prado Júnior B de PA, Covas DT, Rego EM, Santis GC de. Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil [Internet]. Medical Oncology. 2010 ; 27( 4): 1254-1259.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12032-009-9367-9

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Indexado em

Non normalized affiliation